Acetaminophen injection containers recalled after discoloration found in one lot
Baxter Acetaminophen Injection 1000 mg/100 mL in Viaflo containers, lot 24A27G66, is recalled nationwide because of discoloration. 13,000 containers are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers precautionary recalls; the only issue stated is discoloration, with no health consequence described in the notice.
Plain-English summary
Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in a 100 mL Viaflo container and available on prescription only, from Baxter Healthcare Corporation of Deerfield, Illinois and made in Ireland, NDC 36000-306-60, is being recalled. The affected product is lot 24A27G66 with an expiry of 12/31/2025, and the recall covers 13,000 containers distributed nationwide.
The recall was issued because of discoloration. The FDA classified the action as Class II. The notice does not describe any further consequence.
Hospitals and pharmacies holding this lot should quarantine it and follow Baxter's instructions for return or replacement.
The recalled product
- Product
- ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- ACETAMINOPHEN
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — Injectable
- Affected units
- 13,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 24A27G66
- Exp 12/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ACETAMINOPHEN
- SevereFDA Recalls Acetaminophen Injection Due to Labeling Mix-up
FDA (Drugs) · 2024-08-28
- SevereAcetaminophen tablets incorrectly labeled with aspirin drug facts information
FDA (Drugs) · 2024-08-14
- ModerateExtra Strength Acetaminophen 500mg Tablets Recalled for Discoloration
FDA (Drugs) · 2024-07-03
- HighAcetaminophen Injection Recalled for Temperature Storage Abuse Nationwide
FDA (Drugs) · 2022-08-24
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Cefazolin Injection Bags Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- HighBaxter Duo-Vent Solution Set Recalled for Air Bubbles in Tubing
FDA (Devices) · 2026-08-19
- SevereHillrom VOLARA System P.CIRCUIT KIT Medical Device Recall for Oxygen Drop Risk
FDA (Devices) · 2026-07-08
- HighBaxter Head Positioning Adapter May Loosen During Patient Positioning
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA System patient circuits recalled for nebulizer leakage risk
FDA (Devices) · 2026-07-08
Same hazard · discoloration
See all →- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateTavaborole topical solution recalled from three lots because of discoloration
FDA (Drugs) · 2025-10-22
- ModerateTavaborole topical solution recalled after discoloration found in one lot
FDA (Drugs) · 2025-08-27